Not FDA-approved and may not be available in all states
There is no official contraindication preventing concurrent use, and no documented interactions exist between L-carnitine and Mounjaro
GLP-1-induced slowing of gastric motility theoretically could reduce levothyroxine bioavailability, though clinical studies show minimal direct interaction in most patients
Continue reading to learn more about fatigue and the different types of drugs used to treat it
GLP-1 agonists can also increase satiety, reduce feelings of hunger, delay gastric emptying, decrease food cravings, and result in an improvement in eating control
250mcg/5ml (Vial) (EU CTD Available) Palonosetron 250mcg/5ml (Vial) Solution for Injection Reference Product: Aloxi / Helsinn Description: Palonosetron is an antiemetic and antinauseant agent belonging to serotonin (5HT3) antagonists category